Hanson McClain Advisors »

Lucid Diagnostics shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Lucid Diagnostics (LUCD) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Lucid Diagnostics

Tip: Access up to 7 years of quarterly data

All positions including Lucid Diagnostics held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lucid Diagnostics by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $137 167 0.82
2024-06-30 $132 157 0.84
2024-03-31 $128 157 0.82

More positions owned by Hanson McClain Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Ishares Tr Us Treas Bd Etf (GOVT)
Vanguard Index Fds Mid Cap Etf (VO)
Ishares Tr Mbs Etf (MBB)
Apple (AAPL)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
2023 Etf Series Trust Ii Gmo Us Quality E (QLTY)
Ishares Tr Usd Inv Grde Etf (USIG)
Invesco Exch Traded Fd Tr Ii S&p 500 Revenue (RWL)
Ishares Tr Core S&p Ttl Stk (ITOT)

View all positions for Hanson McClain Advisors

Top funds holding Lucid Diagnostics

Luminus Management
Vanguard Group
Geode Capital Management
Nantahala Capital Management
Lido Advisors
Levin Capital Strategies
LPL Financial
Verition Fund Management
Geneos Wealth Management
Two Sigma Securities
BlackRock
BlackRock
State Street Corporation
Tower Research Capital
Northern Trust

View all funds holding Lucid Diagnostics